Article Name North America
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.
23rd September, 2025
The bone-sparing implant, cleared for both anatomic and reverse shoulder arthroplasty, enhances surgical flexibility and patient outcomes while reinforcing the company’s leadership in shoulder care innovation.
23rd September, 2025
The collaboration introduces BD Rowa™ Vmax robotic technology to deliver 24/7 prescription access, streamline pharmacy operations, and empower staff to focus on patient-centred care.
23rd September, 2025
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care.
23rd September, 2025
The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care.
23rd September, 2025
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants.
23rd September, 2025
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks
22nd September, 2025
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe
19th September, 2025
Together, the three devices streamline the procedure by combining effective stone treatment with rapid, controlled clearance
18th September, 2025
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial
17th September, 2025
Expanded indication provides patients with knee osteoarthritis with the benefits of Embosphere’s consistent, predictable, and effective clinical results
15th September, 2025
The results of this study suggest that Nexus Spine's patented technology amounts to a significant improvement over the competing devices
12th September, 2025
GIP acceptance builds on Neu's FDA clearance for Parkinson's tremor measurement and major U.S. health system pilots with entry into America's largest medical innovation hub
12th September, 2025
This collaboration further reinforces Mindray's mission to advance medical technologies to make healthcare more accessible
10th September, 2025
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites
10th September, 2025
New agreement to include the distribution of Medline custom sterile surgical packs
09th September, 2025
Del Medtech is developing transformative, single-use ablation devices designed to improve efficiency and patient outcomes
08th September, 2025
Robust 24-month complete response (CR) rate of 41.8 per cent observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment
08th September, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer